Evidence-Based Medicine Guidelines
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Interferon Beta for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______.
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______. Accessed March 24, 2025.
Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______
Recombinant Interferon Beta for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
ID - 451266
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451266/all/_________Recombinant_interferon_beta_for_delaying_conversion_of_the_first_demyelinating_event_to_multiple_sclerosis______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
